GlobalData

It will present more opportunities to CMOs informs GlobalData, highlighting that in early May, there were 312 novel pipeline drugs…

69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study

Four multinational clinical trials that are planning to enrol the most subjects are investigating remdesivir, sarilumab and…

The main objectives of these projects are to develop solutions to reduce community transmission and identify novel targets with…

The pharma sector registered 16.6 per cent growth as it was meeting the growing demand from healthcare services providers

Favipiravir is the fourth most evaluated repurposed drug after HCQ, lopinavir/ritonavir combination, and recombinant interferon…

WCK 6777 targets multidrug resistance bacterial infections where unmet need is high, translating to an untapped market…

According to GlobalData’s report, ‘Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027, Japan contributed…

Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD)…

The report also states that this may impact the demand and 2Q sales for commonly prescribed drugs involved in the IVF process